Bone Marrow Cells
Our human bone marrow cell portfolio provides an extensive collection of primary cells representing the hematopoietic stem cell niche, bone marrow microenvironment, and disease-associated hematological models. These resources include mononuclear cells, stromal cells, progenitor cells, endothelial cells, plasma samples, and disease-specific bone marrow specimens from a broad spectrum of hematologic malignancies and blood disorders.
Designed to support translational hematology, immunology, stem cell biology, and oncology research, our bone marrow cell collection offers healthy donor-derived materials, patient-derived disease models, and specialized cell populations for mechanistic studies, biomarker discovery, and therapeutic development.
40+
Bone Marrow
Cell Products
20+
Disease-Specific
Models
24-72h
Rapid
Delivery
Filter By:
Our Bone Marrow Cell Portfolio Highlights
Comprehensive Bone Marrow Resources
Our collection encompasses key cellular components of the bone marrow niche and hematopoietic system, supporting both basic and translational research.
-
Diverse Bone Marrow Cell Types
- Bone marrow mononuclear cells, stromal cells, and plasma samples
- CD34+ hematopoietic progenitor cells and CD133+ stem/progenitor cells
- Bone marrow-derived endothelial and feeder cell models
-
Extensive Disease Model Collection
- Leukemia, lymphoma, myeloma, and myelodysplastic syndrome models
- Patient-derived hematologic disease specimens
- Rare blood disorder and genetic disease-associated bone marrow cells
-
Flexible Research Solutions
- Cryopreserved primary cells and matched disease samples
- Customized sourcing and project-specific support
Hematology Research Support
Our bone marrow cell resources support studies across hematopoiesis, oncology, stem cell biology, immunology, and regenerative medicine.
-
Hematopoietic Stem Cell Research
CD34+ and CD133+ cell populations support investigations of stem cell maintenance, lineage commitment, hematopoietic development, and transplantation biology.
-
Hematologic Malignancy Modeling
Patient-derived leukemia, lymphoma, myeloma, and MDS samples provide clinically relevant models for disease mechanism and therapeutic response studies.
-
Bone Marrow Microenvironment Studies
Stromal cells, endothelial cells, and feeder layers enable research on niche regulation, cell-cell interactions, and tumor microenvironment biology.
-
Drug Discovery & Translational Applications
Primary bone marrow cells facilitate biomarker identification, drug screening, immunotherapy development, and precision medicine research.
What types of bone marrow cells are available?
Our portfolio includes bone marrow mononuclear cells, stromal cells, plasma samples, CD34+ hematopoietic progenitor cells, CD133+ stem/progenitor cells, bone marrow-derived endothelial cells, and numerous disease-associated bone marrow models.
Do you provide patient-derived hematologic disease samples?
Yes. We offer primary bone marrow specimens from patients with leukemia, lymphoma, multiple myeloma, myelodysplastic syndrome, aplastic anemia, and other hematologic disorders to support clinically relevant research.
What applications are supported by CD34+ and CD133+ cells?
These stem and progenitor cell populations are widely used for hematopoietic stem cell research, differentiation studies, regenerative medicine, transplantation biology, and cell therapy development.
Can bone marrow stromal cells be used for niche and co-culture studies?
Yes. Bone marrow stromal and feeder cells provide valuable tools for investigating hematopoietic niche biology, cell-cell interactions, stem cell maintenance, and tumor microenvironment regulation.
What quality control tests are performed?
All bone marrow-derived products undergo rigorous quality assessment, which may include cell identity verification, viability testing, morphology evaluation, sterility testing, and mycoplasma detection to ensure reliable experimental performance.